Clinical Genetics · Omaha, NE
NPI
1003203779
Since 2015
Specialty
Clinical Genetics
Code 207SG0201X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
6902 Pine St
Omaha, NE, 68106
Phone (402) 559-6418
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.2M
39 prescriptions
Company payments, 2025
$389
From 5 companies
Medicare prescription drug claims, 2024
In 2024, the drug Craig V Baker prescribed most often to Medicare patients was Buphenyl (Sodium Phenylbutyrate), with 13 prescriptions and refills. In total Craig V Baker wrote 39 Medicare prescriptions that cost $1.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-20.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Buphenyl Sodium Phenylbutyrate | 13 | 13 | Under 11 | $697K |
Brand drugs: 29 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Craig V Baker $389 ($389 in general payments such as food, travel and fees) from 5 companies. The largest payer was Genzyme Corporation with $158.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.